Moreover, VC therapy had no substantial effect on tumor vessel coverage by pericytes, intratumoral hypoxia, and CD8+ T cell infiltration after tumor cGAS deficiency and host STING inhibition (Fig. 10l, Supplementary Fig. 12i). The gene discussed is CD8A; the disease is neoplasm.